Cargando…
FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin
The fms-related tyrosine kinase 3 (FLT3) ligand (FLT3LG) binds to FLT3 on dendritic cells to stimulate their differentiation and expansion, hence facilitating tumor antigen cross-presentation and anticancer immune responses. A recent study by Abrahamsson et al. demonstrates that, in patients receivi...
Autores principales: | Pol, Jonathan G., Le Naour, Julie, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185211/ https://www.ncbi.nlm.nih.gov/pubmed/32363127 http://dx.doi.org/10.1080/2162402X.2020.1755214 |
Ejemplares similares
-
Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models
por: Maiorova, Varvara, et al.
Publicado: (2023) -
Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014) -
Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023) -
A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020) -
Tumor-intrinsic determinants of immunogenic cell death modalities
por: Workenhe, Samuel T, et al.
Publicado: (2021)